Driving Clinical Trial Efficiency in an
Outsourced Model
Presenter: Shad Ayoub, Veeva
Outsourcing in Clinical Trials West Coast
February 13, 2019
Burlingame, CA
2Copyright © Veeva Systems 2018
Objectives
Discuss today’s current state, challenges, and the
industry’s desire to move towards a unified clinical model
Discuss opportunities to transform trial execution through
greater collaboration
How to leverage data for oversight and compliance
Understand the difference between Integrated and
Unified
3Copyright © Veeva Systems 2018
Clinical Trial Process Today
Study Planning and Set-Up
Site Activation
Monitoring and
Study Management
Data Management
Study Closeout
Document Management (TMF)
Site Activation
Tool
eTMF Tool
CTMS
CTMS
EDC
4Copyright © Veeva Systems 2018
The Veeva Unified Clinical Operations Survey
examines the life sciences industry’s progress in
reducing system and process complexity to
improve study execution. This research aims to
understand the drivers, benefits, and barriers of a
unified clinical operating model.
Veeva Unified Clinical Operations Survey
5Copyright © Veeva Systems 2018
Today’s Clinical Technology Landscape
Does your organization utilize applications developed by third-party vendors in
managing clinical studies? If yes, please indicate which are currently in use.
Source: Veeva 2018 Unified Clinical Survey, Q3
Percent of total respondents, N=331
6Copyright © Veeva Systems 2018
Top Challenges Related to Application and Process Silos
What are the biggest challenges, if any, your organization faces in utilizing the clinical
applications identified in question 3? (e.g., CTMS, EDC, eTMF, etc.) Select all that apply.
Source: Veeva 2018 Unified Clinical Survey, Q4
Percent of total respondents, N=331
7Copyright © Veeva Systems 2018
87% of clinical leaders taking action to unify clinical systems and processes
Industrywide Move to A Unified Clinical Model
Source: Veeva 2018 Unified Clinical Survey, Q6
Percent of total respondents, N=331
Does your organization have an initiative underway to better integrate/unify
clinical applications in Q3?
8Copyright © Veeva Systems 2018
Top Drivers for Unified Clinical Operations
Visibility and
Oversight
Faster Trials Study Quality Productivity Collaboration
77% 67% 62% 51% 49%
Source: 2018 Veeva Unified Clinical Operations Survey
Transform Trial Execution through
Collaboration
10Copyright © Veeva Systems 2018
• Security
− Site users should only see content that applies to their site or has been directly shared with them
• Simplicity
− UI for sites should be a simple, secure means to exchange content
− Document re-use across multiple studies can reduce document collection needs
• Task-based Collaboration
− Site users usually interact with Sponsors/ CROs for upload/authoring and acknowledgement of
tasks
Expose Your eTMF to Partners
Site / Sponsor / CRO
Collaboration with eTMF
11Copyright © Veeva Systems 2018
• Consistency
− Document exchange is performed the same regardless of the users involved
• Contemporaneousness
− Documents do not disappear into the void (e.g., email, fax, FedEx/UPS, local drive, etc.)
− Reports on completeness and timeliness are more accurate and meaningful
• Traceability of the Life of a Document
− All activity on a document in the eTMF is captured
• Reporting
− Ability to report on activities performed in the eTMF
Benefits
eTMF Collaboration
12Copyright © Veeva Systems 2018
Passive vs. Active Operating Models
• Paper documents / scanning
• Study teams do not
regularly access the TMF
• TMF is not integrated with
other clinical systems
• No/few manual KPIs or
metrics
PASSIVE ACTIVE
• Electronic documents
managed in system
• Sites, CROs, and sponsor
have eTMF access
• TMF is integrated with other
eClinical systems
• Real-time KPIs and metrics
used for active management
Leverage Data for Oversight,
Compliance, and Decision-making
14Copyright © Veeva Systems 2018
The sponsor should ensure oversight of any
trial-related duties and functions carried out
on its behalf, including trial-related duties and
functions that are subcontracted to another
party by the sponsor’s contracted CRO(s).
INTEGRATED ADDENDUM TO ICH E6(R1):
GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2), November 2016
15Copyright © Veeva Systems 2018
The Power of Reports and Dashboards
• Reports and dashboards can be used as early as study planning and throughout the
life of a study
• Continuous visibility and better oversight of trial activities
Study
Administration
TMF
Planning
Document
Collection
Document
Processing
Closeout &
Archival
16Copyright © Veeva Systems 2018
Historical Forward Looking Custom
How long did it take to approve
documents?
Which documents are approaching
expiration?
How long does it take to resolve
issues during Review?
How many documents have been
reviewed and approved?
Timeline Management
Where are the bottlenecks in a
process?
What is the duration documents
spent in each workflow?
TMF Completeness
How many iterations are needed
with each site prior to completion?
QC, Review, and Approval Cycle
Times
What items need attention?
E.g. Overdue Approvals
How many documents are in the
Approved State?
How many times has a specific user
viewed an approved document?
Inspection Readiness
What is the average time to
Approval?
What Can Reports / Dashboards Provide?
Integrated versus Unified
What’s the Difference?
18Copyright © Veeva Systems 2018
Integrated versus Unified
Title Integrated Unified
Technology
Disparate technologies
Multiple versions
One platform
One version
User Experience
Different User Interfaces
Multiple Logins
One login
Unified experience
Data Flow
Disconnected processes
Broken flow of documents and data
Streamlined processes
Seamless flow of documents and data
Visibility Limited Complete
19Copyright © Veeva Systems 2018
The Impact of Disparate Technologies
Higher Integration and
Maintenance Costs
Reduced Ability to Make
Quick Timely Decisions
Slow and Error-prone
Manual Processes
20Copyright © Veeva Systems 2018
Interim Monitoring Visit Today
21Copyright © Veeva Systems 2018
Interim Monitoring Visit With Unified Suite
22Copyright © Veeva Systems 2018
Site
Activation
Monitor
&
Site Mgmt.
Data Mgmt.
Document
Mgmt.
Study
Planning
Study
Closeout
The Unified Clinical Trial Process
One
Unified Solution
One
Intuitive User
Experience
One
Complete View
Thank You
To read the 2018 Annual CRO Report visit:
http://bit.ly/AnnualCROReport18

Driving Clinical Trial Efficiency in an Outsourced Model

  • 1.
    Driving Clinical TrialEfficiency in an Outsourced Model Presenter: Shad Ayoub, Veeva Outsourcing in Clinical Trials West Coast February 13, 2019 Burlingame, CA
  • 2.
    2Copyright © VeevaSystems 2018 Objectives Discuss today’s current state, challenges, and the industry’s desire to move towards a unified clinical model Discuss opportunities to transform trial execution through greater collaboration How to leverage data for oversight and compliance Understand the difference between Integrated and Unified
  • 3.
    3Copyright © VeevaSystems 2018 Clinical Trial Process Today Study Planning and Set-Up Site Activation Monitoring and Study Management Data Management Study Closeout Document Management (TMF) Site Activation Tool eTMF Tool CTMS CTMS EDC
  • 4.
    4Copyright © VeevaSystems 2018 The Veeva Unified Clinical Operations Survey examines the life sciences industry’s progress in reducing system and process complexity to improve study execution. This research aims to understand the drivers, benefits, and barriers of a unified clinical operating model. Veeva Unified Clinical Operations Survey
  • 5.
    5Copyright © VeevaSystems 2018 Today’s Clinical Technology Landscape Does your organization utilize applications developed by third-party vendors in managing clinical studies? If yes, please indicate which are currently in use. Source: Veeva 2018 Unified Clinical Survey, Q3 Percent of total respondents, N=331
  • 6.
    6Copyright © VeevaSystems 2018 Top Challenges Related to Application and Process Silos What are the biggest challenges, if any, your organization faces in utilizing the clinical applications identified in question 3? (e.g., CTMS, EDC, eTMF, etc.) Select all that apply. Source: Veeva 2018 Unified Clinical Survey, Q4 Percent of total respondents, N=331
  • 7.
    7Copyright © VeevaSystems 2018 87% of clinical leaders taking action to unify clinical systems and processes Industrywide Move to A Unified Clinical Model Source: Veeva 2018 Unified Clinical Survey, Q6 Percent of total respondents, N=331 Does your organization have an initiative underway to better integrate/unify clinical applications in Q3?
  • 8.
    8Copyright © VeevaSystems 2018 Top Drivers for Unified Clinical Operations Visibility and Oversight Faster Trials Study Quality Productivity Collaboration 77% 67% 62% 51% 49% Source: 2018 Veeva Unified Clinical Operations Survey
  • 9.
    Transform Trial Executionthrough Collaboration
  • 10.
    10Copyright © VeevaSystems 2018 • Security − Site users should only see content that applies to their site or has been directly shared with them • Simplicity − UI for sites should be a simple, secure means to exchange content − Document re-use across multiple studies can reduce document collection needs • Task-based Collaboration − Site users usually interact with Sponsors/ CROs for upload/authoring and acknowledgement of tasks Expose Your eTMF to Partners Site / Sponsor / CRO Collaboration with eTMF
  • 11.
    11Copyright © VeevaSystems 2018 • Consistency − Document exchange is performed the same regardless of the users involved • Contemporaneousness − Documents do not disappear into the void (e.g., email, fax, FedEx/UPS, local drive, etc.) − Reports on completeness and timeliness are more accurate and meaningful • Traceability of the Life of a Document − All activity on a document in the eTMF is captured • Reporting − Ability to report on activities performed in the eTMF Benefits eTMF Collaboration
  • 12.
    12Copyright © VeevaSystems 2018 Passive vs. Active Operating Models • Paper documents / scanning • Study teams do not regularly access the TMF • TMF is not integrated with other clinical systems • No/few manual KPIs or metrics PASSIVE ACTIVE • Electronic documents managed in system • Sites, CROs, and sponsor have eTMF access • TMF is integrated with other eClinical systems • Real-time KPIs and metrics used for active management
  • 13.
    Leverage Data forOversight, Compliance, and Decision-making
  • 14.
    14Copyright © VeevaSystems 2018 The sponsor should ensure oversight of any trial-related duties and functions carried out on its behalf, including trial-related duties and functions that are subcontracted to another party by the sponsor’s contracted CRO(s). INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2), November 2016
  • 15.
    15Copyright © VeevaSystems 2018 The Power of Reports and Dashboards • Reports and dashboards can be used as early as study planning and throughout the life of a study • Continuous visibility and better oversight of trial activities Study Administration TMF Planning Document Collection Document Processing Closeout & Archival
  • 16.
    16Copyright © VeevaSystems 2018 Historical Forward Looking Custom How long did it take to approve documents? Which documents are approaching expiration? How long does it take to resolve issues during Review? How many documents have been reviewed and approved? Timeline Management Where are the bottlenecks in a process? What is the duration documents spent in each workflow? TMF Completeness How many iterations are needed with each site prior to completion? QC, Review, and Approval Cycle Times What items need attention? E.g. Overdue Approvals How many documents are in the Approved State? How many times has a specific user viewed an approved document? Inspection Readiness What is the average time to Approval? What Can Reports / Dashboards Provide?
  • 17.
  • 18.
    18Copyright © VeevaSystems 2018 Integrated versus Unified Title Integrated Unified Technology Disparate technologies Multiple versions One platform One version User Experience Different User Interfaces Multiple Logins One login Unified experience Data Flow Disconnected processes Broken flow of documents and data Streamlined processes Seamless flow of documents and data Visibility Limited Complete
  • 19.
    19Copyright © VeevaSystems 2018 The Impact of Disparate Technologies Higher Integration and Maintenance Costs Reduced Ability to Make Quick Timely Decisions Slow and Error-prone Manual Processes
  • 20.
    20Copyright © VeevaSystems 2018 Interim Monitoring Visit Today
  • 21.
    21Copyright © VeevaSystems 2018 Interim Monitoring Visit With Unified Suite
  • 22.
    22Copyright © VeevaSystems 2018 Site Activation Monitor & Site Mgmt. Data Mgmt. Document Mgmt. Study Planning Study Closeout The Unified Clinical Trial Process One Unified Solution One Intuitive User Experience One Complete View
  • 23.
    Thank You To readthe 2018 Annual CRO Report visit: http://bit.ly/AnnualCROReport18